DGI:ZNS-Infektionen/Anmerkung der Redaktion

Anmerkung der Redaktion

Inhaltsverzeichnis

1.       Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K, EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 2;302(21):2323-9

2.       Kumta N, Roberts JA, Lipman J et al. Antibiotic distribution into cerebrospinal fluid: Can dosing safely account for drug and disease factors in the treatment of ventriculostomy-associated infections? Clin Pharmacokinet 2018; 57: 439–454

3.       Blassmann U, Roehr AC, Frey OR, Vetter-Kerkhoff C, Thon N, Hope W, Briegel J, Huge V. Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational study. Crit Care 2016; 20: 343

4.       Conen A, Fux CA, Vajkoczy P, Trampuz A. Management of infections associated with neurosurgical implanted devices. Expert Rev Anti Infect Ther 2017;15(3): 241-255

5.      Nau R et al. S1-Leitlinie Hirnabszess. 2016. In: Deutsche Gesellschaft für Neurologie, Hrsg. Leitlinien für Diagnostik und Therapie in der Neurologie. Online: www.dgn.org/leitlinien

6.       Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Scheld WM, van de Beek D, Bleck TB, Garton HJL, Zunt JR. 2017 Infectious Diseases Society of America’s Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. Clin Infect Dis 2017; 64: e34–e65

7.      Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen - Update 2018 https://www.awmf.org/leitlinien/detail/ll/082-006.html

8.         Schaberg T, et al., Tuberculosis Guideline for Adults - Guideline for Diagnosis and Treatment of Tuberculosis including LTBI Testing and Treatment of the German Central Committee (DZK) and the German Respiratory Society (DGP). Pneumologie 2017; 71(6): 325-397

9.         Wilkinson RJ, et al., Tuberculous meningitis. Nat Rev Neurol, 2017; 13(10): 581-598

10.         Ducomble T, et al., The burden of extrapulmonary and meningitis tuberculosis: an investigation of national surveillance data, Germany, 2002 to 2009. Euro Surveill, 2013; 18(12)

11.         in Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for Its Prevention and Control. 2011; London

12.         Thwaites G, et al., British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect, 2009; 59(3): 167-87

13.         Marais S, et al., Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome. Clin Infect Dis, 2013; 56(3): 450-60

14.         Chin JH, Tuberculous meningitis: Diagnostic and therapeutic challenges. Neurol Clin Pract, 2014; 4(3):199-205

15.         Marais S, et al., Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis, 2010; 10(11): 803-12

16.         Amagon KI, Awodele O and Akindele AJ, Methionine and vitamin B-complex ameliorate antitubercular drugs-induced toxicity in exposed patients. Pharmacol Res Perspect, 2017; 5(5)

17.       Prasad K and Singh MB, Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev, 2008(1); CD002244

18.       Thwaites GE, et al., Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med, 2004; 351(17): 1741-51

19.         Darlow CA, et al., Microbial aetiology of brain abscess in a UK cohort: Prominent role of Streptococcus intermedius. J Infect, 2020; 80(6): 623-629

20.         RN, S1-Leitlinie Hirnabszess In: Deutsche Gesellschaft für Neurologie, Hrsg. Leitlinien für Diagnostik und Therapie in der Neurologie, 2016

21.         Alvis Miranda H, et al., Brain abscess: Current management. J Neurosci Rural Pract, 2013; 4(Suppl 1): S67-81

22.         Brouwer MC, et al., Brain abscess. N Engl J Med, 2014; 371(5): 447-56

23.         Mishra AM, et al., Comparison of the magnetization transfer ratio and fluid-attenuated inversion recovery imaging signal intensity in differentiation of various cystic intracranial mass lesions and its correlation with biological parameters. J Magn Reson Imaging, 2006; 24(1): 52-6

24.         Xu XX, et al., Can diffusion-weighted imaging be used to differentiate brain abscess from other ring-enhancing brain lesions? A meta-analysis. Clin Radiol, 2014; 69(9): 909-15

25.         Mishra AK, et al., Molecular revolution in the diagnosis of microbial brain abscesses. Eur J Clin Microbiol Infect Dis, 2014; 33(12): 2083-93

26.         Sonneville R, et al., An update on bacterial brain abscess in immunocompetent patients. Clin Microbiol Infect, 2017; 23(9): 614-620

27.         Sharma R, Mohandas K, and Cooke RP, Intracranial abscesses: changes in epidemiology and management over five decades in Merseyside. Infection, 2009; 37(1): 39-43

28.            Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Michael Scheld W, van de Beek D, Bleck TP, Garton HJ, Zunt JR: 2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. Clin Infect Dis 2017; 64: e34–e65

29.            Reyes MM, Munigala S, Church EL, Kulik TB, Keyrouz SG, Zipfel GJ, Warren DK: Comparing External Ventricular Drains-Related Ventriculitis Surveillance Definitions. Infect Control Hosp Epidemiol 2017; 38(5):574-579

30.            Beer R, Lackner P, Pfausler B, Schmutzhard E: Nosocomial ventriculitis and meningitis in neurocritical care patients. J Neurol 2008; 255(11):1617-1624

31.            Ambulant erworbene bakterielle (eitrige) Meningoenzephalitis im Erwachsenenalter, AWMF-Registernummer: 030/089 [https://www.awmf.org/leitlinien/detail/ll/030-089.html]

32.            Nau R, Blei C, Eiffert H: Intrathecal Antibacterial and Antifungal Therapies. Clin Microbiol Rev 2020; 33(3)

33.            Karvouniaris M, Brotis AG, Tsiamalou P, Fountas KN: The Role of Intraventricular Antibiotics in the Treatment of Nosocomial Ventriculitis/Meningitis from Gram-Negative Pathogens: A Systematic Review and Meta-Analysis. World Neurosurg 2018; 120:e637-e650

34.            Nau R, Seele J, Djukic M, Eiffert H: Pharmacokinetics and pharmacodynamics of antibiotics in central nervous system infections. Curr Opin Infect Dis 2018; 31(1):57-68

35.            Nau R, Sorgel F, Eiffert H: Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev 2010; 23(4):858-883

36.            Nau R, Sorgel F, Prange HW: Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections. Clin Pharmacokinet 1998; 35(3):223-246

37.          Mader MM, Czorlich P, Konig C, Fuhrmann V, Kluge S, Westphal M, Grensemann J: Intrathecal penetration of meropenem and vancomycin administered by continuous infusion in patients suffering from ventriculitis-a retrospective analysis. Acta Neurochir (Wien) 2018; 160(11):2099-2105

38.          Tangden T, Enblad P, Ullberg M, Sjolin J: Neurosurgical gram-negative bacillary ventriculitis and meningitis: a retrospective study evaluating the efficacy of intraventricular gentamicin therapy in 31 consecutive cases. Clin Infect Dis 2011; 52(11):1310-1316

39.     Pfister H-W et al., Ambulant erworbene bakterielle (eitrige) Meningoenzephalitis im Erwachsenenalter. S2k-Leitlinie. AWMF-Registriernummer: 030/089

40.     Brouwer MC et al., Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev 2010;. 23: p. 467-492

41.     Van de Beek D et al., Community-acquired bacterial meningitis. Nat Rev Dis Primers 2016; 2: 16074

42.     Van de Beek D et al., Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004. 351:1849-1859

43.     Klein M et al., Bakterielle Infektionen des Zentralnervensystems. Nervenarzt 2010; 81: 150-161

44.     Bijlsma MW et al., Community-acquired bacterial meningitis in adults in the Netherlands, 2006-2014; a prospective cohort study. Lancet Infect Dis 2016; 16: 339-347

45.     Thigpen MC et al., Bacterial Menigitis in the United States, 1998-2007. N Engl. J Med 2011; 364:2016-2025

46.     McGill F et al., Acute bacterial meningitis in adults. Lancet 2016; 388:3036-3047

47.     Aubertin M et al., Detrimental role of delayed antibiotic administration and penicillin-nonsuceptible strains in adult intensive care unit patients with pneumococcal meningitis: The PNEUMOREA prospective multicenter study. Crit Care Med 2006; 34: 2758-2765

48.  Domingues RB et al., Performance of lactate in discriminating bacterial meningits from enterviral meningits. Rev Inst Med Trop Sao Paulo 2019; 61: e 24

49.  Ehrenstein BP et al., Neue Entwicklungen in Diagnostik und Therapie der akuten bakteriellen Meningitis. Med Klinik 2005; 100: 325-333

50.  Tan YC et al., Treatment strategies for central nervous system infections: an update. Expert Opin Pharmacother 2015; 16: 187-203

51.  Wie T-T et al., Diagnostic accuracy of procalcitonin in bacterial meningitis versus nonbacterial meningitis. Medicine 2016; 95: e3079

52.  Jing-Zi P et al., Detection of bacterial meningitis pathogens by PCR-mass-spectrometry in cerebrospinal fluid. Clin Lab 2018; 64: 1013-1019

53.  Albuquerque RC et al., Multiplex-PCR for diagnosis of bacterial meningitis. Braz J Microbiol 2019; 50:435-443

54.  Glimaker M et al., Adult bacterial meningitis: Earlier treatment and improved outcome following guideline revision promoting prompt lumbar puncture. Clin Infect Dis 2015; 60:1162-1169

55.  Glimaker M et al., Lumbar puncture performded promptly or after neuroimaging in acute bacterial meningitis in adults: a prospective national cohort study evaluating different guidelines. Clin Infect Dis 2018; 66:321-328

56.  Ettekoven CN et al., Update on community-acquired bacterial meningitis: guidance and challanges. Clin Microbiol Infect 2017; 23: 601-606

57.  Van den Beek D et al., Community-acquired bacterial meningitis. Nat Rev 2016; Doi:10.1038/nrdp2016.74

58.  Sandiumenge A et al., Therapy of ventilator-associated pneumonia. A patient-based approach based on the ten rules of „The Tarragona Strategy“. Intensive Care Med 2003; 29: 876-883

59.   Nau R et al.: Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev 2010; 23: 858-883

60. 

Blassmann U, Roehr AC, Frey OR, Vetter-Kerkhoff C, Thon N, Hope W, Briegel J, Huge V. Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational study. Crit Care 2016; 20: 343

61.  Tattevin P et al., Understanding central nervous system efficacy of antimicrobials. Intensive Care Med 2019; 45: 93-96

62.   De Gans J et al., Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002; 347: 1549-1556

63.  Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Scheld WM, van de Beek D, Bleck TB, Garton HJL, Zunt JR. 2017 Infectious Diseases Society of America’s Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. Clin Infect Dis 2017; 64: e34–e65

64.  Costerus JM et al., Communitiy-acquired bacterial meningitis. Curr Opin Infect Dis 2017; 30: 135-141

65.  Shah PM et al., Bakterielle Meningitis. In PEG S2k Leitlinie: Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen – Update 2018 (AWMF-Registriernummer 082-006)

66.  Glimaker M et al., Neuro-Intensive treatment targeting intracranial hypertension improves outcome in severe bacterial meningitis: An intervention-control study. PLOS ONE 2014; 9: e91976. doi:10.1371

67.  Mourvillier B et al., Induced hypothermia in severe bacterial meningitis. A randomized clinical trial. JAMA 2013; 310:2174-2183

68.  Ajdukiewicz K et al., A double blind, randomised controlled trial of glycerol adjuvant therapy in adult bacterial meningitis in a high HIC seroprevalence setting in Malawi. Lancet Infect Dis 2011; 11:293-300

69.  Castelblanco RL et al., Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population-based observational study. Lancet Infect Dis 2014; 14: 813-819

70.  Martin NG et al., Hospital admission rates for meningitis and septicaemia caused by Haemophilus influenzae, Neisseiria meningitidis, and Streptococcus pneumoniae in children in England over five decades: a population-based observational study. Lancet Infect Dis 2014; 14: 397-405